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repeat units within the B domain. We propose that CNA is indeed a mosaic protein in which the different
domains previously indicated by sequence analysis operate independently.
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ABSTRACT: Sequence analysis of surface proteins from Gram-positive bacteria indicates a composite
organization consisting of unique and repeated segments. Thus, these proteins may contain discrete domains
that could fold independently. In this paper, we have used a panel of biophysical methods, including gel
permeation chromatography, analytical ultracentrifugation, circular dichroism, and fluorescence spectros-
copy, to analyze the structural organization of the Staphylococcus aureus collagen adhesin, CNA. Our
results indicate that the structure, function, and folding of the ligand-binding domain (A) are not affected
by the presence or absence of the other major domain (B). In addition, little or no interaction is observed
between the nearly identical repeat units within the B domain. We propose that CNA is indeed a mosaic
protein in which the different domains previously indicated by sequence analysis operate independently.
Bacterial adherence to the host tissue is the first critical
step in the pathogenic process of most infections. Organisms
that cause infections in the extracellular space colonize the
extracellular matrix. This adherence is mediated by a
subfamily of bacterial surface proteins called MSCRAMMs1
(1-3). During the past decade several MSCRAMMs on
Gram-positive bacteria have been identified and partially
characterized (for reviews, see references 4-6). Sequence
analyses of the MSCRAMMs revealed a common structural
theme composed of unique and repeated sequences, and a
multidomain organization of these proteins was therefore
proposed. One such MSCRAMM, the collagen adhesin,
CNA (Figure 1a), is present on some strains of Staphylo-
coccus aureus and is composed of a N-terminal signal
sequence followed by a 55 kDa segment of unique sequence
called the A domain. This domain is followed by the B
domain, which is composed of a 23 kDa subunit that is
repeated 1-4 times in CNA from different S. aureus strains
(7). The C-terminal portion of the protein consists of a cell
wall attachment region, that contains the cell wall anchoring
site LPKTG, a hydrophobic transmembrane region and a
short cytoplasmic tail composed primarily of positively
charged residues. It is believed that the protein is cleaved
at the cell wall anchoring site and becomes covalently linked
to the cell wall (8).
CNA mediates bacterial adherence to collagenous tissues
such as cartilage, a process that is important in the patho-
genesis of septic arthritis caused by Staphylococci. An
isogenic mutant in which the cna gene has been inactivated
is considerably less virulent than the wild-type CNA-
expressing bacteria in a mouse model of septic arthritis (9).
Furthermore, a S. aureus strain that normally lacks the cna
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1 Abbreviations: MSCRAMMs, microbial surface components rec-
ognizing adhesive matrix molecules; CNA, Staphylococcus aureus
collagen adhesin; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide
gel electrophoresis; EDTA, ethylenediaminetetraacetic acid; ESI/MS,
electrospray ionization mass spectrometry; UV/vis, ultraviolet/visible;
CD, circular dichroism; SPR, surface plasmon resonance spectroscopy;
HEPES, N-(2-hydroxyethyl)piperazine-N′-2-ethanesulfonic acid; BSA,
bovine serum albumin; amino acids are represented by standard one-
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FIGURE 1: (a) Schematic of the S. aureus FDA 574 collagen-binding
MSCRAMM, CNA. The putative signal peptide (S), nonrepetitive
binding domain (A), domain of three subunits (B1B2B3), cell wall
domain (W), membrane spanning domain (M), and charged
carboxyl-terminal domain (C) are indicated. (b) Recombinant CNA
proteins used in this study that mimic portions of the collagen-
binding MSCRAMM, with the inclusive residues indicated. The A
domain subfragment (M19) for which the crystal structure has been
solved spans residues 151-318 (11). MRGSHHHHHHGS is the
amino acid sequence of the unstructured His6-tag required for
purification.
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gene becomes more virulent in this model when the cna gene
is introduced (9). Recent studies suggest that the recombi-
nant CNA A domain, when used as a vaccine, provides
protection in a mouse model of staphylococcal-induced sepsis
(10).
The collagen-binding function of CNA has been located
to the A domain, and a recombinant protein containing a 19
kDa subfragment of the A domain has collagen-binding
activity (11), although a recombinant version of the full-
length A domain appears to bind collagen more effectively
than the shorter subfragment (12). We recently solved the
crystal structure of the 19 kDa collagen-binding subfragment
(13). This polypeptide folds as a jellyroll composed of two
â-sheets connected by two short R-helices. One of the
â-sheets has a noticeable “trench” transversing it. Molecular
modeling studies showed that this trench can accommodate
a collagen triple helix, and analyses of single point mutations
in the trench suggest this does in fact represent the collagen-
binding site and several residues making contact along the
extended collagen macromolecule. Such a binding scheme
has been suggested recently for other collagen-binding
proteins (14, 15).
The B domain of CNA in S. aureus strain FDA 574 is a
triplet of repeat units. The first and third repeat units of the
B domain are sequentially identical; the second varies by a
single residue: residue N566, which is located in the central
part of the B repeat unit in B1, is replaced by D753 in B2.
The importance of the CNA B repeat units is unclear. Recent
work by Hartford et al. showed that expression of a CNA
construct in which the B domain repeat units were deleted
resulted in presentation of a truncated, but functional,
collagen-binding MSCRAMM on the bacterial surface (16).
These B domain repeat units could affect the function or
the stability of the A domain, they may serve as a “stalk”,
projecting the A domain away from the bacterial surface and
positioning the A domain for binding to collagen, or they
may possess binding sites for ligands other than collagen.
The structural organization of this MSCRAMM, the
interaction between domains, and the role of the B domain
in collagen binding (or possible alternative function in S.
aureus pathogenicity) of the MSCRAMM have not been
previously examined. In this report, we have used a panel
of biophysical methods to characterize recombinant forms
of the A domain, a B repeat unit, a heterodimeric AB
construct, and a homodimeric BB construct (Figure 1b) with
the intent to determine their structural and functional
relationships.
EXPERIMENTAL PROCEDURES
Construction of Expression Plasmids. The expression
plasmids pQE-A, pQE-AB1, pQE-B1, and pQE-B1B2 were
constructed based on the vector pQE-30 (Qiagen Inc.,
Chatsworth, CA) using standard molecular biology protocols
(17, 18). Recombinant proteins expressed from this vector
contain an N-terminal tail of six histidine residues. DNAs
encoding the various gene fragments were obtained by
polymerase chain reaction using S. aureus FDA 574 genomic
DNA (19) as a template and the oligonucleotides shown in
Table 1 as primers. The amplified gene fragments, contain-
ing BamHI and SalI restriction sites at the 5′- and 3′-ends,
respectively, were introduced into the oligonucleotides,
treated with proteinase K, phenol/chloroform extracted, and
ethanol-precipitated as described by Crowe et al. (20). Each
of the fragments was then digested with the BamHI and SalI
restriction endonucleases, purified by agarose gel electro-
phoresis (Geneclean kit, ISC BioExpress), and ligated to the
vector pQE-30 (previously linearized by digestion with the
same endonucleases). Ligation mixtures were transformed
into E. coli strain JM101. Plasmids from isolated transfor-
mants were analyzed by restriction digestions and automated
DNA sequencing analysis (Molecular Genetics Core Facility,
UT-Houston Medical School) to confirm the expected open
reading frame. The published sequence (8, 11) is identical
to the now-determined sequence except for the following:
Arg399fAla, Ile665fThr, and Ile852fThr.
Bacterial Growth Conditions. Recombinant E. coli (JM101)
were grown at 37 °C in Luria Broth (Life Technologies)
containing 100 íg/mL ampicillin. Overnight cultures of
stationary-phase bacteria were used to inoculate fresh media
(1:1000), and the cells were allowed to grow until OD600 nm
) 0.6-0.8 (approximately 6 h). Protein expression was
induced by addition of isopropylthio-â-D-galactoside to a
final concentration of 0.2 mM, and the culture was incubated
for an additional 3 h. Bacteria were collected by centrifuga-
tion and resuspended in a minimal volume of 5 mM
imidazole, 100 mM NaCl, 4 mM Tris-HCl, pH 7.9, and
frozen at -70 °C.
Isolation of Recombinant Proteins. Cell pellets were
thawed, passed through a French press (11 000 lb/in2) 3 times
to lyse the cells, and centrifuged at 14 krpm for 20 min to
remove cell debris and insoluble proteins. The supernatants
were filtered through a 0.45 ím membrane, and recombinant
proteins were purified using metal-chelating affinity chro-
matography. Bacterial lysates were applied to a HR10/10
(Pharmacia) column of nickel-charged iminodiacetic acid
Sepharose (Sigma), and bound protein was eluted with a 200
mL linear gradient of 0-200 mM imidazole in 4 mM Tris-
HCl, 100 mM NaCl, pH 7.9. In general, this purification
step yielded proteins that were >95% pure as estimated by
SDS-PAGE. The recombinant AB1 preparation, however,
required an additional purification step. Fractions containing
Table 1: Synthetic Oligonucleotides Used in Plasmid Constructions
construct base pairs amino acids oligonucleotidea
A 238-1744 30-531b BamHI primer #5: 5′-GCGGATCCGCACGAGATATTTCA-3′
JP3 primer: 5′-CGGTCGACTTATTCAGTATTAGTAACCAC-3′
AB1 238-2314 30-721 BamHI primer #5: 5′-GCGGATCCGCACGAGATATTTCA-3′
B1 (3′) primer: 5′-CGCGTCGACTTATGGCGTATATTTATTCGT-3′
B1 1753-2314 535-721 B1 (5′) primer: 5′-CGCGGATCCGAAACAACATCAATTAGT-3′
B1 (3′) primer: 5′-CGCGTCGACTTATGGCGTATATTTATTCGT-3′
B1B2 1753-2875 535-908 B1 (5′) primer: 5′-CGCGGATCCGAAACAACATCAATTAGT-3′
B1 (3′) primer: 5′-CGCGTCGACTTATGGCGTATATTTATTCGT-3′
a Restriction endonuclease sites are in boldface type. b Not including N-terminal histidine tag.
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recombinant AB1 (as determined by SDS-PAGE) were
pooled and dialyzed against 20 mM tris-HCl, pH 8.0, before
being applied to a HR10/10 Q Sepharose column (Pharma-
cia). Bound protein was then eluted using a 100 mL gradient
of 0-0.5 M NaCl, 20 mM Tris-HCl, pH 8.0. During all
chromatographic procedures, the eluate was monitored by
absorbance at 280 nm and collected fractions were examined
for purity by SDS-PAGE. Fractions containing only the
desired product were pooled and concentrated using an
Amincon ultrafiltration system. Concentrated proteins were
then dialyzed extensively against 10 mM Na2HPO4, 100 mM
NaCl, pH 7.0, fast-frozen, and kept at -70 °C until use.
Verification of Protein Identity. To verify the protein’s
identities, electrospray mass spectrometry measurements of
each were performed at the University of Texas-Houston
Health Science Center. Samples were dialyzed 3  1 L
against 50 mM EDTA in water to remove Ni2+, and then
dialyzed 3  1 L against water to remove excess EDTA.
All aqueous stock sample solutions were diluted with ESI/
MS solvent, consisting of 100/100/10 (v/v/v) methanol/water/
glacial acetic acid. Instrument setup and calibration were
performed using a mixture of horse skeletal muscle apomyo-
globin and BSA (2.5 pmol/íL each) in ESI/MS solvent.
Analyses were performed using a Finnigan TSQ70 (upgraded
to TSQ700) mass spectrometer fitted with a modified Vestec
ESI source. Duplicate spectra were acquired for each
sample. The instrument was calibrated before each run using
a series of standards; deviation between theoretical and
measured molecular masses of the standards was consistently
less than 0.02%. Table 2 lists the molecular mass of each
recombinant protein as determined from the amino acid
sequence, measured by mass spectrometry, and calculated
from sedimentation velocity parameters.
Gel Permeation Chromatography. Effective radii were
measured at room temperature using gel-permeation chro-
matography. Protein samples were diluted in 10 mM Na2-
HPO4, 100 mM NaCl, pH 7.0, applied to a HR10/30
Superdex 200 column, and eluted with the same buffer at a
flow rate of 0.5 mL/min. The column was calibrated using
a standard globular protein kit (Pharmacia). Radii were then
calculated using sample elution volumes and standard curves
as described in the calibration kit.
Sedimentation Velocity Measurements. Prior to analysis,
protein solutions were dialyzed 3  1 L against 10 mM Na2-
HPO4, pH 7.0, to remove NaCl that may damage the
instrument’s centerpieces. Experiments were performed
using a Beckman XL-A analytical ultracentrifuge, equipped
with an AN-60 Ti four-position rotor and absorption optics.
All samples were centrifuged at 20 °C and 60 krpm in
double-sector aluminum centerpieces. Sedimentation data
were analyzed with the UltraScan software package2 using
the van Holde-Weischet (21), second moment (22), and
finite element analysis (23, 24) methods. The van Holde-
Weischet method was used to confirm sample homogeneity
and identify the possible concentration dependence of the
sedimentation coefficient, s. The second moment method
was used to ensure that the scans included in the analysis
did not exhibit time-dependent variations such as aggregation,
degradation, or pelleting. Finally, to determine the sedi-
mentation and diffusion coefficients, the experimental data
were fit directly to a finite element solution of the Lamm
equation as described by Demeler and Saber (25). The
partial specific volume, îj, of each protein was estimated from
the amino acid sequence by the method of Sober (26) and
was temperature-corrected. To model the overall geometry
of the molecules, axial ratios were estimated for prolate and
oblate ellipsoids from the experimentally determined sedi-
mentation and diffusion coefficients as described in ref 27.
Absorption Spectroscopy. Absorption measurements were
taken at ambient temperature (23 ( 2 °C) using a Beckman
DU-70 UV/vis spectrophotometer and a 1.0 cm path length
cuvette. All spectra were corrected for background signal,
and the reported absorbance maxima are (1.0 nm. Since
the proteins in this study all contain chromophoric amino
acids, the concentration of each protein solution was
determined spectrophotometrically using the Edelhoch method
of UV-light absorption (28). Extinction coefficients were
experimentally determined as described by Gill and von
Hippel (29), employing Pace et al.’s values for the extinction
coefficients of the individual residues (30, 31).
Steady-State Fluorescence Spectroscopy. Fluorescence
excitation and emission spectra were collected at ambient
temperature using an Aminco SLM 4800C fluorimeter
equipped with a 450 W xenon lamp, employing excitation
and emission band-passes of 2 nm. The excitation source
was set at 295 nm to preferentially select tryptophyl emission.
Protein samples, in 10 mM Na2HPO4, 100 mM NaCl, pH
7.0, were stirred throughout each scan to prevent photo-
bleaching. All scans were background-subtracted, and all
reported maxima were reproducible within (1.0 nm. The
relative fluorescence quantum yields, F(x), were determined
using the calculations outlined by Petrich and co-workers
(32):
2 A sedimentation data analysis software package developed by one
of the authors (B. Demeler).
Table 2: Summary of Physical Parameters
molecular mass (kDa)a
species sequence mass spec sed vel îj (cm3/g) s20,w (S)b D20,w (cm2/s)  107 b effective radius (Å)c F/Fo
A 56586 56627 58189 0.7263 3.27 4.98 39.1 (31.6) 1.68
AB1 78120 78130 77722 0.7248 4.28 4.88 42.8 (35.6) 1.56
B1 22612 22587 24846 0.7168 2.30 7.93 26.3 (22.5) 1.42
B1B2 43807 43754 40582 0.7186 3.46 7.35 31.3 (28.8) 1.29
a Values represent molecular mass calculated from the published sequence, mass spectrometry, and sedimentation velocity measurements,
respectively. b Sedimentation coefficients obtained from the finite element analysis and calculated using the molecular weight determined by
sedimentation velocity. c Assuming a hydrated sphere. The data shown here are an average of values obtained by gel-permeation chromatography
and sedimentation velocity measurements. Radii expected for globular proteins of these molecular masses are shown in parentheses and calculated
from formulas outlined by Uversky (46).
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where OD(x) is the optical density of recombinant protein x
at the excitation wavelength and Iem(x,î) is the emission
intensity at the excitation wavelength. For these studies,
fluorescence quantum yields were determined relative to that
of CNA B1. Chaotropic protein denaturation was induced
by equilibrating the samples overnight with 6.0 M guanidine
hydrochloride (ultrapure grade, USBiochem), 10 mM Na2-
HPO4, 100 mM NaCl, pH 7.0, at ambient temperature.
Emission spectra of guanadine hydrochloride in buffer were
subtracted from the corresponding sample scans.
Time-ResolVed Fluorescence Emission Anisotropy. Pro-
teins were labeled with Texas Red Sulfonyl Chloride (Pierce
Chemical) to measure rotational tumbling ratios. Each
protein was diluted into 10 mM Na2HPO4, 100 mM NaCl,
pH 9.0, to a final concentration of 0.2 mg/mL. The labeling
was performed as previously described (33, 34), with the
following modifications. One milligram of Texas Red
(ìabsmax ) 596 nm in buffered aqueous solution) was added
to the protein solution, which was then mixed gently and
incubated at room temperature for 1 h. To remove excess
dye, the protein solution was dialyzed exhaustively against
10 mM Na2HPO4, 100 mM NaCl, pH 7.0.
Fluorescence lifetimes, K(t), and fluorescence anisotropy
decays, r(t), were obtained using the time-correlated, single-
photon counting technique (35, 36). A time scale of
approximately 15 ns was used to collect the fluorescence
decays. All measurements were performed at 20.3 °C and
with ìex ) 570 nm and ìem > 610 nm. The anisotropy
decays of the proteins were fit to the function r(t) ) r1(0)
exp(-t/ôr1) + r2(0) exp(-t/ôr2), with the short time constant
fixed at the value obtained for the probe alone. Calculations
for the determination of the order parameter and hypothetical
cone semiangle are described in ref 32.
Circular Dichroism (CD). Far-UV circular dichroism data
were collected using a Jasco J720 spectropolarimeter cali-
brated with d-10-camphorsulfonic acid, employing a band-
pass of 1 nm and integrated for 4 s at 0.2 nm intervals. All
sample concentrations were less than 15 íM in 1 mM Na2-
HPO4, 10 mM NaCl, pH 7.0. Spectra were recorded at
ambient temperature in cylindrical 0.5 mm path length
cuvettes.
Twenty scans were averaged for each spectrum, the
contribution from buffer was subtracted, and quantitation of
secondary structural components was performed using
software provided by N. J. Greenfield (UMDNJ-Robert
Wood Johnson Medical School, Piscataway, NJ) and D.
Greenwood (Softwood Co., Brookfield, CT). We initially
used four deconvolution programs (SELCON, VARSLC1,
CONTIN, and CD estima) that were derived from databases
of known protein structures (37-40). The reliability of these
programs in predicting the secondary structure of CNA
domains was assessed by analyzing the spectra obtained for
M19, a truncated form (19 kDa, residues 151-318) of the
A domain that encompasses the collagen-binding region. The
structure of M19 has been solved using X-ray crystallography
and consists of 8% R-helix, 53% â-sheet, and 39% coil (13).
The CONTIN analysis consistently yielded exaggerated
â-sheet content, while the CD estima program dramatically
underreported the percentage of â-sheet structure. Averaging
data from all four programs yielded the same results as
comparison of SELCON and VARSLC1 only, but with
significant error (up to 50%). As a result, we have chosen
to report an average of results obtained from the SELCON
and VARSLC1 analyses only. For M19, this yielded
secondary structure percentages that are comparable to the
data obtained from the crystallographic analysis: 12 ( 4%
R-helix, 49 ( 4% â-sheet, and 39 ( 13% other components.
Thermal Denaturation. Protein unfolding was induced by
heat and monitored by far-UV CD. The thermal denaturation
(ramp rate of 20 °C/h) of each protein in 1 mM Na2HPO4,
10 mM NaCl, pH 7.0, was followed at 208 nm by far-UV
CD using the parameters described above. The reversibility
of the thermal denaturation was determined immediately after
the unfolding analyses, and the samples were cooled at a
ramp rate of 20 °C/h.
Surface Plasmon Resonance Spectroscopy (SPR). Analy-
ses were performed using the BIAcore system. Bovine type
I collagen (Collagen Corp., Fremont, CA) was immobilized
on a CM5 sensor chip as described previously (11).
Recombinant CNA proteins in 150 mM NaCl, 50 mM
HEPES, 0.05% P-20 surfactant, pH 7.4, were flowed over
three flow cells containing different amounts of immobilized
collagen. All data were corrected for the response obtained
using a flow cell that was not coated with collagen.
Analytical conditions and data analysis were as described
previously (12, 41). No mass transport effects were observed
in these measurements.
ELISA Assays. Microtiter plates were coated with 10 íg
of type I collagen per well in 10 mM Na2HPO4, 100 mM
NaCl, pH 7.0, overnight at 4 °C. Collagen-coated wells were
then washed with the same buffer and incubated for 1 h in
the presence of 5% BSA in 10 mM Na2HPO4, 100 mM NaCl,
pH 7.0. Wells were again washed with buffer, and varying
concentrations of recombinant CNA protein, in buffer
containing 0.1% BSA, were added. After 3 h, unbound
protein was removed by washing the wells with the same
buffer. To detect bound protein, the wells were incubated
with a monoclonal antibody that recognizes the histidine tag
of the recombinant proteins (6xHis Monoclonal Antibody,
Clontech), followed by alkaline phosphatase-conjugated goat
anti-mouse IgG antibody. Relative binding was measured
by monitoring the sample absorbance at 405 nm following
the addition of p-nitrophenyl phosphate in 1 M diethanola-
mine, 0.5 mM MgCl2, pH 9.0.
RESULTS
Expression and Purification of Recombinant Proteins
Mimicking Regions of CNA. A model of the collagen-
binding MSCRAMM from S. aureus FDA 574 has been
described previously, in which a multidomain nature of this
protein was proposed (8). We have now analyzed recom-
binant proteins containing individual (A and B1), ho-
modimeric (B1B2), and heterodimeric (AB1) domains of the
MSCRAMM with the goal to evaluate this model. SDS-
PAGE, followed by staining with Coomassie Brilliant Blue,
revealed that each preparation of recombinant protein
migrated as a single band, but at unexpectedly high molecular
masses due to their acidic natures (Figure 2). No degradation
F(x)
F(B1)
) 1 - 10
-OD(B1)
1 - 10-OD(x)
s0∞Iem(x,V) dV
s0∞Iem(B1,V) dV
(1)
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or multimerization was observed for any of these recombi-
nant proteins over a period of several weeks when the
proteins were stored at -70 °C. However, attempts to
express the full-length CNA protein (AB1B2B3) from a pQE-
based vector yielded no detectable amounts of soluble intact
protein.
Structure of the CNA A Domain. Analysis of the
recombinant CNA A domain by gel-permeation chromatog-
raphy showed that the protein eluted significantly earlier than
what was expected for a globular protein with a molecular
mass of 57 kDa as compared with the elution positions of
globular protein standards. From these measurements, we
calculated that the effective radius (the protein’s radius
assuming it folds as a fully hydrated sphere) of the A domain
was 39.1 Å, compared with 31.6 Å for a globular protein of
similar mass (Table 2). Sedimentation velocity measure-
ments using a Beckman XL-A analytical ultracentrifuge did
not indicate aggregation of the A domain over a wide range
of concentrations and yielded a F/Fo ratio of 1.68 (Figure 3,
Table 2). If we assume a prolate ellipsoid model for this
protein, the calculated axial ratio would be 12.8. Hence,
the recombinant CNA A domain is significantly nonglobular.
The far-UV CD spectrum of this protein contains a
minimum at 215 nm and relative maxima at 198 and 232
nm (Figure 4a). Deconvolution of this spectrum revealed
that the full-length A domain recombinant is a primarily
â-sheet protein that contains a small percentage R-helix
(Table 3). This composition of secondary structure elements
is similar to that for M19, the CNA A domain truncate that
encompasses the collagen-binding motif (11), for which the
crystal structure was recently solved (13). Thermal dena-
turation, as followed by intensity of the far-UV CD spectrum,
revealed that the A domain is quite thermostable and unfolds
reversibly over a range of 30 °C (60-90 °C), undergoing a
multiphasic thermal denaturation with a highly populated
intermediate state apparent at approximately 74 °C (Figure
5).
The recombinant A domain protein exhibits an absorbance
maximum of 278 nm and has an experimentally determined
extinction coefficient of 58 740 M-1 cm-1. The fluorescence
quantum yield of A is 15% of that for B1, and the five
tryptophans of the A domain reside in an overall nonpolar
environment (ìemmax ) 330 nm when ìex ) 295 nm) as shown
by steady-state emission spectroscopy. The A domain’s
tryptophyl emission spectrum red-shifts upon denaturation
in 6 M guanidine hydrochloride (ìemmax ) 352 nm) as all
tryptophans become fully solvated.
FIGURE 2: SDS-PAGE analysis of recombinant His6-CNA proteins
depicted in Figure 1b. Affinity-purified fusion proteins were
fractionated by electrophoresis on a 12% polyacrylamide gel, and
the proteins were stained with Coomassie Brilliant Blue. Lane 1,
molecular mass standards; lane 2, A; lane 3, B1; lane 4, AB1; lane
5, B1B2.
FIGURE 3: Integral distribution plots, G(s), for the recombinant
CNA protein as obtained from the van Holde-Weischet method.
The data shown refer to diffusion, temperature, and buffer-corrected
s-value distributions for 100% of the boundary analyzed. A fraction
of 0.5 refers to the midpoint in the sedimentation velocity boundary.
The negative slope of the distribution of A and AB1 indicates slight
solution nonideality due to concentration dependence of the
sedimentation coefficient, s. All distributions indicate sample
homogeneity.
FIGURE 4: Circular dichroism of recombinant CNA proteins. (a)
Far-UV spectra of A, B1, and B1B2 illustrating the unique secondary
structure of the A domain and the similarity between the monomeric
and dimeric B repeat units. (b) Far-UV spectra of AB1, measured
and calculated. The mathematical construction of the calculated
spectrum is described in the text. Secondary structural compositions
are listed in Table 3. Mean residue weight molar ellipticity reported
in degâcm2/dmol.
Table 3: Summary of Secondary Structural Componentsa
species R-helix â-sheet other
A 0.09 ( 0.04 0.49 ( 0.02 0.42 ( 0.09
AB1 0.08 ( 0.07 0.50 ( 0.02 0.42 ( 0.10
B1 0.08 ( 0.06 0.41 ( 0.03 0.52 ( 0.11
B1B2 0.07 ( 0.05 0.44 ( 0.02 0.49 ( 0.10
a Values reported here are an average of results obtains using
SELCON and VARSLC1 deconvolution programs. Refer to Experi-
mental Procedures for further details.
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Structure of a CNA B Domain Repeat Unit. We propose
that the structural data obtained for the B1 subunit are valid
for any single repeat unit of the B domain since the amino
acid sequences of the repeat units are so similar (>99% of
the residues are identical). Gel-permeation chromatography
measurements of B1 revealed that this protein eluted earlier
than would be expected for a protein of this molecular mass,
yielding an effective radius of 26.3 Å (versus 22.5 Å for a
globular protein of the same mass, Table 2). Sedimentation
velocity analyses demonstrated that a single repeat unit is
monomeric in solution (Figure 3), and attempts to induce
dimerization at high protein concentrations (>200 íM) in
order to mimic the B1B2 recombinant were unsuccessful. In
addition, the sedimentation velocity measurements gave a
F/Fo ratio of 1.42. When modeled as a prolate ellipsoid,
this would represent a shape with an axial ratio of 7.7.
Together, the gel-permeation chromatography and sedimen-
tation velocity results indicate that a CNA B domain repeat
unit is nonglobular.
The far-UV CD spectrum of B1 contains a relative
minimum at 214 nm, maxima at 203 and 228 nm, and
significant negative molar ellipticity at 190 nm (Figure 4a).
These characteristics are typical of a structure rich in â-sheet.
Deconvolution of this spectrum yielded secondary structural
content that resembles that of the A domain (Table 3).
However, the arrangement of the secondary structural motifs
in the two domains is clearly not the same since the far-UV
CD spectra of the two proteins are quite different. Heat
denaturation of the recombinant single B domain repeat unit
followed by changes in the far-UV CD spectrum demon-
strated that this single repeat unit is particularly stable with
respect to heat, denaturing reversibly in the range 68-82
°C via an apparently single, sharp transition (Figure 5).
The absorbance maximum of the recombinant B1 repeat
unit is 278 nm, and the extinction coefficient is 37 070 M-1
cm-1. The five tryptophans of a B domain repeat unit reside
in an environment that is much more polar than that of the
A domain tryptophans. The maximum of the emission
spectrum for B1 occurs at 340 nm (ìex ) 295 nm), 12 nm
red-shifted from that for the A domain. In 6 M guanidine
hydrochloride, all hydrophobicity of the tryptophans’ local
environments is removed and the tryptophyl emission
maximum shifts to 352 nm.
No Structural Rearrangements Occur upon B Repeat Unit
Dimerization. The recombinant B1B2 protein is a dimer of
two B repeat units covalently linked at the C-terminus of
the first and the N-terminus of the second. Since the
sequence of the second repeat unit of the CNA B domain
mimics exactly that of the first except for one residue (and
the third repeat unit is identical to the first), we suggest that
this dimer, B1B2, is a model for any two covalently joined
B domain repeat units. The far-UV CD spectrum of B1B2
overlays that obtained for B1 (Figure 4a), implying that the
secondary structures of the B repeat units do not change
dramatically when they are covalently linked in series.
Deconvolution of the far-UV CD spectrum produced the
same composition of structural components as for B1, as was
expected (Table 3). In addition, the secondary structural
elements in B1B2 denature upon heating apparently as they
do in B1, for the completely reversible thermal denaturation
of B1B2 occurs at 70-82 °C and is also a simple, two-state
transition (Figure 5).
Gel-permeation chromatography measurements indicate
that the effective radius of B1B2 is somewhat greater than
that expected for a 44 kDa globular protein (31.3 vs 28.8 Å,
Table 2). Sedimentation velocity experiments determined
that neither degradation nor multimer formation of B1B2
occurs at high protein concentrations and the protein has a
F/Fo ratio of 1.29 (Figure 3, Table 2). B1B2, therefore, also
is nonglobular, yet not to the extent that B1 is.
The absorption spectrum of the recombinant B1B2 het-
erodimer has a maximum of 278 nm, and the protein’s
extinction coefficient is 74 450 M-1 cm-1. The 10 tryp-
tophans of B1B2 are in an environment comparable with those
of B1 (ìemmax ) 341 nm, ìex ) 295 nm). B1B2’s fluorescence
quantum yield is twice that of B1. In fact, a theoretical
construction of the B1B2 emission spectrum shown in Figure
6a closely duplicated the measured spectrum of B1B2 (the
theoretical construction of the emission spectrum from eq 3
is discussed in detail below for AB1). The emission
maximum of B1B2 in 6 M guanidine hydrochloride shifts to
352 nm as all tryptophans become completely solvated upon
protein denaturation.
We would expect that if no significant structural reorga-
nization occurs among the B repeat units upon joining to
form the dimer, B1B2 would have a significantly greater
diameter than B1. One method to compare relative protein
sizes employs time-resolved fluorescence anisotropy. This
technique follows the rotation of molecules in solution. Since
large proteins tumble slower than small ones, we would
expect the anisotropy decay (and, therefore, the rotational
rate) of B1B2 to be much longer lived than that of B1 if the
individual repeats fold independently and are simply joined
by a polypeptide tether sequence. For this analysis, B1 and
B1B2 were labeled with the visible light fluorescent probe
Texas Red, and emission greater than 610 nm was collected.
The fluorescence lifetime of the Texas Red probe fit well
to a single exponential of 4.2 ns. The fluorescence lifetime
of this label did not change dramatically upon attachment
to the B1 (or B1B2) recombinant protein. The fluorescence
lifetime decays of B1 and B1B2 both fit to an exponential of
the form: K(t) ) A1 exp(-t/ôf1) + A2 exp(-t/ôf2) ) 0.80
exp(-t/4.5 ns) + 0.20 exp(-t/1.0 ns), indicating that the local
environment of the probe was similar in these two proteins.
FIGURE 5: Thermal denaturation profiles of recombinant CNA
proteins as monitored by far-UV CD.The midpoints of thermal
unfolding (Tm) are 65 ( 2 °C and 86 ( 5 °C for A, 70 ( 2 °C for
AB1, 74 ( 1 °C for B1, and 77 ( 1 °C for B1B2.
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The anisotropy decay of the Texas Red dye alone in
solution fit well to a single exponential of 240 ps (ł2 ) 1.38)
(Figure 7a). If the data were fit to two exponentials, a long
component [ôr2 ) 15.9 ns; r1(0) ) 0.13, r2(0) ) 0.01] was
observed. This results in a hypothetical cone semiangle, ıO
(within which the transition dipole moment can diffuse), of
approximately 90°, as was expected for the probe free in
solution.
The fluorescence anisotropy decay of B1 tagged with Texas
Red fit well to two exponentially decaying components: r(t)
) r1(0) exp(-t/ôr1) + r2(0) exp(-t/ôr2) ) 0.09 exp(-t/0.24
ns) + 0.12 exp(-t/8.8 ns), ł2 ) 1.25 (Figure 7b). This
indicates that we were probing the rapid librational motion
of the probe with respect to the recombinant protein as well
as the overall tumbling motion of the protein macromolecule
itself. The rotational anisotropy data for B1B2 were also
resolved into two components: r(t) ) 0.06 exp(-t/0.24 ns)
+ 0.15 exp(-t/11.9 ns), ł2 ) 1.26 (Figure 7c). The second
component of the anisotropy decay (ôr2) of B1B2 is substan-
tially longer-lived than that of B1, as would be expected for
a molecule of greater length. The hypothetical cone semi-
angle was determined to be approximately 34° for Texas
Red attached to B1 and 27° for B1B2. The fluorescent probe’s
significant cone semiangle of rotation was characteristic of
a loosely tethered moiety, as would be expected for the dye
molecule attached at the N-terminus of the unstructured
histidine tag of B1. The cone semiangle of rotation of the
probe varied little between B1 and B1B2, implying that no
dramatic conformational change occurred at the N-terminal
protein face upon dimerization.
FIGURE 6: Comparison of the fluorescence emission spectra of
recombinant CNA proteins. (a) B1 and B1B2. The dashed line is
the construction of a B1B2 spectrum using the B1 spectrum, where
B1B2(calcd spectrum) ) 2  B1(measd spectrum). (b) A, B1, and
AB1. The dashed line is the construction of the AB1 spectrum using
eq 3. All sample concentrations were 1.0 íM, and ìex ) 295 nm.
FIGURE 7: Parallel and perpendicular fluorescence intensity profiles
of the recombinant CNA proteins from which the anisotropy decay
is calculated (ìex ) 570 nm, ìem > 610 nm, 20.3 °C). (a) The
fluorescent probe Texas Red alone in solution; (b) the labeled single
B domain repeat unit, B1; (c) the labeled B domain repeat unit
dimer, B1B2. The residuals corresponding to emission polarized
parallel and perpendicular to the excitation source are overlaid above
each panel. All time-resolved measurements have an error of
approximately 10%.
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No Structural Rearrangements Occur upon Forming the
AB1 Heterodimer. The heterodimeric construct AB1 consists
of a B1 repeat unit linked via its N-terminus to the C-terminus
of the A domain. The far-UV CD spectrum of AB1 is
indicative of a protein having significant â-sheet character,
with an intensity minimum at 214 nm and relative maxima
at 200 and 229 nm. The composition of secondary structural
components of AB1 is similar to that of the other constructs
(Table 3), yet its profile (Figure 4b) does not superimpose
that of the recombinant A or B domain shown in Figure 4a.
However, if the percentages and arrangements of R-helix,
â-sheet, and other components of A and B1 do not undergo
any change upon forming AB1, a calculated far-UV CD
spectrum may be constructed from the weighted sum of A
and B1’s spectra that duplicates the observed AB1 spectrum
in Figure 4b:
where residues is the number of amino acids in each protein.
This is indeed the case: the theoretical construction and
measured curve are nearly superimposable (Figure 4b).
Hence, the organization of secondary structure components
in A and B1 is the same in the individual recombinants and
the heterodimer.
The effective radius (42.8 Å) of AB1 is significantly greater
than expected for a globular 78 kDa protein. This protein
is monomeric by sedimentation velocity analysis (Figure 3),
and its F/Fo ratio of 1.56 is intermediate between those of
A and B1, indicating a shape less globular than B1, but more
so than A alone.
The thermal unfolding of AB1 is complex: no obvious
intermediate state is observed, and the transition from native
to denatured protein is diffuse, with a Tm of 70 °C and a
dynamic range of more than 25 °C (Figure 5). This would
indicate a denaturation via an unresolved intermediate state.
Unlike the unfolding of the other recombinants, the dena-
turation of AB1 is not completely reversible: only ap-
proximately 70% of the original AB1 conformation is
regained upon cooling.
The absorbance maximum of the recombinant AB1 het-
erodimer is 278 nm, and its extinction coefficient is 92 750
M-1 cm-1. From the steady-state emission spectrum of AB1,
we conclude that its 10 tryptophans reside in an overall
environment of intermediate polarity (ìemmax ) 337 nm, ìex
) 295 nm) in relation to the other 3 recombinant proteins
in this study. The fluorescence quantum yield of AB1 is
0.85 with respect to B1. As is expected, the fluorescence
emission spectrum of AB1 in 6 M guanadine hydrochloride
indicates all 10 tryptophans become fully solvated upon
denaturation.
A theoretical construction similar to that described above
for the secondary structure of AB1 (eq 2) may be used to
determine the change, if any, in tertiary structure upon
forming the mixed-domain protein. A theoretical fluores-
cence emission spectrum of (A + B1) may be constructed
based on the relative quantum yields (A has a fluorescence
quantum yield of 0.15 with respect to B1) and spectra shape
and positions of the individual A and B1 units:
where IAB1(calc’d) is the calculated emission spectrum of
AB1, (Frel)A is the quantum yield of A relative to B1, and IA
is the emission intensity of the A domain protein. If the
tryptophan environments of both A and B1 are not altered
upon complexation (for example, surface-exposed tryp-
tophans of the A and B1 proteins becoming buried in the
A-B1 interface), this calculated spectrum should duplicate
the observed AB1 spectrum in Figure 6b. The observed and
calculated spectra are nearly identical, providing additional
evidence that (1) the local environments about the tryp-
tophans in the recombinant heterodimer are no different than
their environments in the individual domain recombinants
and (2) no tryptophans reside at the A-B1 interface.
Collagen Binding Is Not Influenced by the B Domain. An
ELISA demonstrating the four CNA recombinant proteins
binding to immobilized type I collagen is shown in Figure
8. Neither B1 nor B1B2 exhibited collagen-binding activity.
In this assay, the affinities of A and AB1 for collagen were
comparable. Figure 9 illustrates the normalized SPR re-
sponses of A and AB1 flowed over a BIAcore sensor chip
coated with type I collagen (the responses of B1 and B1B2
were undetectable). It is apparent from these SPR profiles
FIGURE 8: Relative binding of immobilized type I collagen (100
íg/mL) by A (O), AB1 (b), B1 (0), and B1B2 (9) as a function of
recombinant CNA protein concentration. BSA bound type I collagen
at levels comparable to those of recombinant CNA B1B2. Half-
maximal binding of recombinant CNA A and AB1 was calculated
to be 1.9 ( 0.4 and 2.9 ( 0.9 íM, respectively.
[ı]AB1(calc’d) )
(residues)A([ı])A + (residues)B1([ı])B1
(residues)AB1
(2)
FIGURE 9: Representative profiles of the normalized SPR responses
for the binding of 1.0 íM recombinant CNA A (s) and AB1 (âââ)
to immobilized type I collagen. In the analyses shown here, the
4-min injection (begun at 100 s) employed a flow rate of 5 íL/
min.
IAB1(calc’d) )
(Frel)A(IA) + (Frel)B1(IB1)
(Frel)A + (Frel)B1
(3)
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that addition of the B1 repeat unit to the A domain does not
significantly affect the association and dissociation rates of
the protein/collagen interaction. In addition, the CNA
recombinant A and AB1 proteins compete for sites within
the collagen macromolecule. Figure 10 demonstrates the
inhibition of AB1 by biotinylated A, in which the collagen
binding of AB1 was completely blocked by A. The reverse
experiment yielded similar results: the inhibition of A by
AB1 is complete (data not shown). Data in Figures 8-10
illustrate that the presence of a B domain repeat unit does
not alter the collagen-binding characteristics of the A domain.
DISCUSSION
The Organization of the A Domain. The recombinant A
domain encompasses the motif of the binding domain
truncate, M19 [which includes a trench where, in modeling
studies, a triple-helical peptide mimicking collagen was found
to fit (13)]. However, the full-length A domain of CNA
expressed as a recombinant binds collagen with a higher
apparent affinity and specificity: fewer high-affinity sites
are found for A compared to M19, and the KD’s for the high-
affinity binding sites of these two species are 0.3 and 3.0
íM, respectively (12). These results may suggest a model
where amino acid residues outside the sequence encompass-
ing M19 continue the structural fold determined by M19.
Perhaps the collagen-binding trench in the native protein is
extended and involves residues outside the sequence encom-
passed by M19. An alternative model would suggest that
the A domain is composed of subunits that fold indepen-
dently but may interact to make up the structure of this
protein. The presence of an intermediate state in the complex
denaturation of the A domain (Figure 5) may support this
suggestion, since subunits having different stabilities with
respect to heat could yield such a unfolding profile. In this
second model, M19 could represent such a subunit. At the
present time, we cannot differentiate between these two
models.
A and B Domains BehaVe Independently. Analytical
ultracentrifugation measurements demonstrated that the AB1
heterodimer is more spherical than the A domain, suggesting
that the two subunits do not have simply end-to-end joining.
To determine whether this behavior is due to reorganization
of the two subunits upon joining, we compared the far-UV
CD and emission spectra, thermal denaturation profiles, and
collagen-binding capabilities of A and AB1.
Theoretical far-UV CD and tryptophyl emission spectra
of AB1, calculated using eqs 2 and 3, are shown in Figures
4b and 6b. These spectra closely match those obtained
experimentally; hence, neither the secondary nor the tertiary
structural elements within the A and B1 subunits undergo
detectable reorganization when the two are joined.
Is the complex thermal denaturation observed for AB1
unique to the heterodimer, a consequence of an interaction
between the two domains, or merely a composite of A and
B1 unfolding simultaneously? If the denaturation observed
for AB1 is due only to a sum of the individual subunits (A
and B1) unfolding independently, we should be able to model
the curve for AB1 in Figure 5 by averaging the denaturation
curves of A and B1. The calculated and observed denatur-
ation curves overlay (data not shown), indicating that (1)
each subunit unfolds independently and (2) no changes in
stability occur as the heterodimer is formed.
This comparison of theoretical and measured profiles of
the far-UV CD, emission, and denaturation confirms that the
overlap between A and B1 in the heterodimer does not alter
the structure or stability of the two subunits. These results,
in conjuction with the collagen-binding measurements shown
in Figures 8-10, suggest that the CNA A and B domains
do not interact. A plausible construction of the CNA
MSCRAMM is shown in Figure 11. In this arrangement,
the AB1 heterodimer would be more globular than the A
domain alone, and the two domains make little, if any,
contact.
A Model for the CNA B Domain. The far-UV CD spectra
of B1 and B1B2 are very similar, indicating that little, if any,
alteration in the secondary structure of the individual repeat
units occurs upon formation of the B1B2 dimer. Not only
do B1 and B1B2 have the same percentages of R-helix and
â-sheet structural motifs as resolved by a variety of spectral
deconvolution programs (Table 3), but also their far-UV CD
spectra are almost identical (Figure 4a). The loss of
secondary structural organization upon heating occurs simi-
larly for the monomeric and dimeric B domain proteins. No
intermediate states in the denaturation were observed for
either protein, and the temperature ranges over which the
two proteins unfold were alike (Figure 5). A slight increase
in Tm is apparent in the dimer, perhaps due to the enhanced
FIGURE 10: Inhibition of recombinant CNA AB1 to immobilized
type I collagen by biotinylated recombinant CNA A. The biotiny-
lated and unbiotinylated species were allowed to bind simulta-
neously to the immobilized collagen. The dark circles represent
self-inhibition (i.e., inhibition of A binding to immobilized type I
collagen by biotinylated A), measured as a control. The data points
represent average values of duplicate assays.
FIGURE 11: Cartoon drawing of the proposed organization of S.
aureus CNA anchored to the cell surface. For simplicity, only the
A and B domains are shown.
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stability arising from hydrogen bonds and/or the interaction
of hydrophobic surfaces at the B1-B2 interface (42).
It is unlikely that the difference in Tm for B1B2 compared
to B1 is due to an increased hydrophobicity of tryptophans
at the B1-B2 interface, however. From a comparison of
emission spectra (Figure 6a), it is evident that the overall
tryptophyl environments of B1 and B1B2 are quite similar.
No obvious rearrangement of subunit tertiary structure occurs
nor do any of the five tryptophans that may be surface-
exposed in a single B repeat unit become buried in the
interface as two B repeat units are joined.
Forming the B1B2 homodimer causes an decrease in the
sedimentation velocity frictional ratios (Table 2), implying
that the axial ratios and frictional ratio of B1B2 are less than
those of B1. This observation suggests that the interface is
not a simple end-to-end stacking of the repeat units. The
time-resolved fluorescence anisotropy measurements provide
supporting evidence for the more globular nature of B1B2
compared to B1. The anisotropy decay is longer-lived for
B1B2 than B1, but not tremendously so. If the two repeat
units stacked end-to-end, making the dimer a significantly
more elongated molecule, we would expect the anisotropy
decay of the dimer to be even longer-lived. We propose
that the B domain repeat units in CNA join as depicted in
Figure 11, where at each unit juncture the protein folds
somewhat back onto itself. Since no structural or functional
interaction is observed between the repeat units of B1B2, we
conclude that there is little significant contact among any of
the B domain repeat units.
That (1) no observable reorganization of the secondary or
tertiary structure occurs and (2) no dramatic differences upon
denaturation are detected upon forming the B1B2 dimer
confirms that the two repeat units of B1B2 fold independently
and in the same manner as the single B1 unit does. We
propose that this autonomy is preserved regardless of the
number of repeat units present within a particular strain of
CNA-containing S. aureus. Consequently, we limited the
mixed-domain analyses to the AB1 recombinant and suggest
that this construct is representative of all constructs that
include the A domain and any number of B repeat units.
Since the A and B domains (and the repeat units within the
B domain) are independent, extrapolation of characteristics
of the CNA recombinants in vitro to those of the S. aureus
MSCRAMM in vivo is possible. It must be kept in mind
that if domain cooperativity in protein folding, stability, or
collagen binding had been observed, this would not be the
case.
No ligand binding has yet been identified for the B domain
repeat units, and a B domain is apparently not necessary for
presenting a functional binding A domain on the surface of
S. aureus cells. Furthermore, the studies presented here
suggest that the B domain does not influence the collagen-
binding activity of the A domain and the function of the B
domain remains unclear.
CNA May Be a Model for Other MSCRAMM Proteins.
Surface proteins on Gram-positive bacteria are often com-
posed of unique and repeated sequences. The repeated
sequences in a particular protein can occur in different copy
numbers depending on the strain of origin. For example,
the B domain in CNA may contain 1, 2, 3, or 4 repeats of
a 23 kDa unit in the protein from different isolates. This
structural organization, which is derived from sequence
analysis, suggests that the MSCRAMMs are mosaic proteins.
In this study, we demonstrate that CNA is an example of a
protein in which genetic motifs translate into individual
structural and functional domains in the protein. Further-
more, the CNA A and B domains are independent structurally
and functionally, as are the repeat units within the B domain.
Thus, CNA is a true mosaic protein. We suggest that these
characteristics may be valid for MSCRAMMS in general.
Bottomley et al. concluded from their studies of S. aureus
protein A, SpA, that the joining the domains in SpA does
not affect the structure of the individual domains (43). Also,
preliminary analyses of the relationship between domains
within other MSCRAMMs support our hypothesis (unpub-
lished results).
The occurrence of different numbers of repeat units in the
same protein expressed by nonrelated isolates may have
arisen from intragenic recombination, where homologous
sequences on each side of the repeat unit represent target
sites for crossover. Intronless splicing has recently been
suggested to be important in the evolution of prokaryotic
protein families. These recer sequences (recombination
spacer) are located as structureless links between domains
and represent target sites for recombination events. Bjo¨rck
and co-workers described a specific recer sequence presum-
ably involved in the shuffling of modules in surface proteins
among Peptostreptococcus magnus strains (44, 45). The
recer sequence identified in P. magnus is not found in S.
aureus FDA 574 cna, but perhaps other recer classes have
evolved among S. aureus strains. Future studies will
undoubtedly address these possibilities.
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